SymphonyRM

About SymphonyRM

SymphonyRM, which rebranded to Actium Health in September 2021, operates as a healthcare technology company focused on patient engagement and relationship management. The company was founded in 2014 by Michael Linnert, who serves as the CEO. Linnert and his team brought 15 to 20 years of experience in customer relationship management from other consumer-facing industries, applying those principles to healthcare.

The company's core business revolves around its AI-powered platform that analyzes health system data to generate personalized "Next Best Actions" (NBAs) for each patient. This enables healthcare providers and payers to move from a reactive to a proactive engagement model, anticipating patient needs and facilitating outreach. The platform ingests disparate data sources, such as electronic medical records (EMR), claims, and capacity data, to create a comprehensive 360-degree view of the customer. By using machine learning, the system identifies and prioritizes opportunities for outreach related to preventative care, managing chronic conditions, or addressing care gaps. The business model appears to be a subscription-based managed service, which includes data science, customer success, and change management support.

SymphonyRM targets health systems, including hospitals and payer organizations, as its primary clients. The platform provides actionable intelligence for various departments such as marketing, call centers, and physician relationship management to help them acquire, engage, and retain patients. By personalizing communication and making it easier for patients to take action, the service aims to improve health outcomes, increase revenue, and enhance patient loyalty for its clients. The company has demonstrated significant financial traction, raising $10 million in a Series A round in 2019 and a subsequent $25 million in a Series B round in May 2021, led by TT Capital Partners with participation from Adams Street Partners.